Tag: Atrial Fibrillation
No Proof Azithromycin Ups Odds of Ventricular Arrhythmia
Patients on azithromycin no more likely to develop ventricular arrhythmia than those on amoxicillin
Larger Women Have Nearly Three-Fold Higher Risk of A-Fib
Risk of atrial fibrillation rises along with body size, but remain low overall, researchers say
Lower Risk of Gastrointestinal Bleeding for Apixaban
In non-valvular a-fib patients, risk of GI bleeding down for apixaban vs. rivaroxaban, dabigatran
Apixaban Tx Cost in A-Fib Meets U.S. Norms for Reasonable Value
Incremental cost of achieving longer life expectancy within accepted U.S. norm ($53,925/QALY)
ACC: Antithrombotic Benefit Found Lacking in Low-Risk A-Fib
Researchers found low-risk patients fared better without any antithrombotic therapy
Many A-Fib Patients Not Getting Appropriate Anticoagulation Rx
More than 80 percent of ischemic stroke patients weren't getting adequate anticoagulation
ACC: Zika Linked to Negative Cardiovascular Effects in Adults
Eight Venezuelan patients developed arrhythmias, heart failure after infection
NOACs Have Been Widely Adopted Into Practice
Non-vitamin K antagonist oral anticoagulants prescribed more often than vitamin K antagonists
Hospitalizations for Atrial Fibrillation on the Rise
But patients with the condition also more likely to survive, researchers say
TGF-β1 Linked to Recurrent A-Fib After Catheter Ablation
Patients with paroxysmal atrial fibrillation have highest levels of transforming growth factor-β1
